Neuriva may support certain memory-test results, but there is no published evidence here that it treats dementia or Alzheimer's disease. Its published trial involved healthy middle-aged adults with self-reported memory problems—not people diagnosed with dementia. Neuriva is a dietary supplement marketed for memory, focus, learning, accuracy, and concentration. Those claims should not be confused with preventing cognitive decline or treating a disease.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the Neuriva study find?
- Why doesn't the trial answer the dementia question?
- What is in Neuriva Original?
- What do the FDA disclaimers mean?
- Questions to ask before buying
What did the Neuriva study find?
The published randomized trial enrolled 138 healthy adults ages 40 to 65. Participants reported memory problems but did not have a dementia diagnosis. They took Neuriva or a placebo for 42 days. According to the 2023 trial indexed by PubMed, the Neuriva group showed some placebo-adjusted improvements in computerized tests.
These included working-memory accuracy, reaction time, and picture-recognition accuracy. Other measures did not show significant differences between the groups. These included brain-derived neurotrophic factor, or BDNF; an everyday-memory questionnaire; and a Go/No-Go test of attention and response control. This mixed result matters. Improvement on selected computer tasks does not establish that the supplement improves everyday functioning, slows dementia, or changes the course of Alzheimer's disease.
Why doesn't the trial answer the dementia question?
The participants were healthy adults between 40 and 65, while the question facing many families concerns a diagnosed, progressive disease. Results from one group cannot automatically be applied to another with different health needs and cognitive problems. The study also lasted only 42 days. That period may reveal short-term changes on tests, but it cannot show whether Neuriva produces lasting benefits or affects dementia progression.
Four study authors were Reckitt employees. An industry connection does not automatically invalidate research, but it is an important limitation when weighing a single short trial. More broadly, the National Institute on Aging says no vitamin or supplement has been proven to prevent Alzheimer's disease in people. It recommends no supplement for preventing Alzheimer's or cognitive decline.
What is in Neuriva Original?
The manufacturer identifies two main ingredients: decaffeinated coffee-cherry extract, sold as Neurofactor, and plant-sourced phosphatidylserine. The product is marketed for general brain-support goals rather than dementia treatment.
A U.S. government supplement-label record lists the amounts in one capsule of Neuriva Original: The label also advises people to consult a clinician before use if they are pregnant, breastfeeding, taking medication, or living with a medical condition. That warning is especially relevant for someone receiving treatment for dementia or another chronic illness.
- Coffee-fruit extract: 100 milligrams
- Phosphatidylserine: 100 milligrams
- Allergen information: soy
What do the FDA disclaimers mean?
Neuriva is a dietary supplement, not an FDA-approved dementia medicine. Its manufacturer states that the product is not intended to diagnose, treat, cure, or prevent disease. The FDA explains that it does not approve dietary supplements for safety or effectiveness before they go on sale.
A product's availability therefore does not mean the agency has confirmed its memory claims. Supplements can also interact with medicines or other supplements. The FDA advises discussing their use with a clinician, rather than assuming that a product labeled "natural" is suitable for every person.
Questions to ask before buying
Start by identifying the goal. A person seeking help with ordinary, self-reported forgetfulness is not in the same situation as someone with diagnosed dementia.
The published Neuriva study speaks only to the first group. Before purchasing, ask: Bring the bottle or label to that conversation. Neuriva Original lists 100 milligrams each of coffee-fruit extract and phosphatidylserine per capsule, which gives the clinician specific ingredients and doses to review.
- Am I expecting general brain support or treatment for dementia?
- Does the available research include people with the same diagnosis and age range?
- Are selected computer-test improvements meaningful for the person's daily life?
- Could the soy content be a concern?
- Could the supplement interact with current medicines or other supplements?
